“A Study of JNJ-70033093 (BMS-986177) in Healthy Adult Participants”
The purpose of this study is to characterize the pharmacokinetic (PK) of multiple twice-daily doses of JNJ-70033093 in healthy participants and to assess the effects of dosing time and food on the PK of single-dose of JNJ-70033093 in healthy participants.
Drug - JNJ-70033093
JNJ-70033093 capsules will be administered orally .
Drug - Placebo
Matching placebo in capsule will be administered orally.
A Phase 1, Open-label Single-dose Crossover, and Double-blind Multiple-dose Parallel Group Study to Characterize the Pharmacokinetics, Safety and Tolerability, and Pharmacodynamics of JNJ-70033093 in Healthy Adult Subjects